Hint mode is switched on Switch off

LABU - Direxion Daily S&P Biotech Bull 3X Shares (USD) (US25460G1206)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access

Choose all Reset all

Leveraged

 
(%)
US25460G1206
LABU ISIN
Exchange Traded Funds (ETF)
Type of fund
Direxion Funds
Provider
273.5 USD
NAV per Share | 13/08/2026
28/05/2015
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
LABU
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
The S&P Biotechnology Select Industry Index
Benchmark
0.93 %
Total Cost Ratio
594.72 mln USD
Fund NAV | 13/08/2026
594.72 mln USD
Share Class NAV | 13/08/2026
No
UCITS
20 / 1 (02/12/2023)
Split
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Yield on 14/08/2026, NYSE Arca

  • YTD
    1.98 %
  • 1M
    -23.81 %
  • 3M
    -3.65 %
  • 6M
    17.4 %
  • 1Y
    219.99 %
  • 3Y
    27.39 %
  • 5Y
    -86.86 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (LABU)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

LABU profile

The Direxion Daily S&P Biotech Bull 3X Shares (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Direxion Funds fund’s base currency is USD and the share class was registered 28.05.2015 with unique ISIN - US25460G1206. Main exchange is NYSE Arca and ticker symbol is LABU. The total expense ratio is 0.93%. The Direxion Daily S&P Biotech Bull 3X Shares (USD) pays dividends 4 time(s) per year.

Structure LABU on 14/08/2026

Download structure in Excel
Paper Value
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 53.08%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 50.85%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 48.34%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 41.19%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 32.54%
GOLDMAN FINL SQ TRSRY INST 506 22.73%
DREYFUS GOVT CASH MAN INS 14.33%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 4.39%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 2.86%
GOLDMAN SACHS FIN GOV 465 INSTITUT 2.25%
TWIST BIOSCIENCE CORP 1.18%
ORUKA THERAPEUTICS INC 1.08%
APOGEE THERAPEUTICS INC 1.04%
PRAXIS PRECISION MEDICINES I 0.97%
KYMERA THERAPEUTICS INC 0.93%
NATERA INC 0.91%
DIANTHUS THERAPEUTICS INC 0.91%
PROTAGONIST THERAPEUTICS INC 0.91%
HALOZYME THERAPEUTICS INC 0.91%
REVOLUTION MEDICINES INC 0.89%
MODERNA INC 0.88%
INSMED INC 0.88%
CG ONCOLOGY INC 0.87%
SPYRE THERAPEUTICS INC 0.86%
RHYTHM PHARMACEUTICALS INC 0.86%
REGENERON PHARMACEUTICALS 0.85%
ERASCA INC 0.85%
TRAVERE THERAPEUTICS INC 0.84%
VAXCYTE INC 0.83%
ROIVANT SCIENCES LTD 0.81%
RELAY THERAPEUTICS INC 0.8%
AMGEN INC 0.79%
BIOMARIN PHARMACEUTICAL INC 0.78%
ARROWHEAD PHARMACEUTICALS IN 0.77%
BRIDGEBIO PHARMA INC 0.77%
SCHOLAR ROCK HOLDING CORP 0.77%
COGENT BIOSCIENCES INC 0.76%
VIKING THERAPEUTICS INC 0.76%
VERTEX PHARMACEUTICALS INC 0.75%
INCYTE CORP 0.73%
GILEAD SCIENCES INC 0.72%
ACADIA PHARMACEUTICALS INC 0.72%
UNIQURE NV 0.72%
ALKERMES PLC 0.72%
ABBVIE INC 0.71%
CYTOKINETICS INC 0.7%
CRISPR THERAPEUTICS AG 0.7%
BIOGEN INC 0.69%
DYNE THERAPEUTICS INC 0.69%
IMMUNOVANT INC 0.69%
MADRIGAL PHARMACEUTICALS INC 0.69%
SELLAS LIFE SCIENCES GROUP I 0.68%
KRYSTAL BIOTECH INC 0.67%
MIRUM PHARMACEUTICALS INC 0.67%
SUMMIT THERAPEUTICS INC 0.67%
TG THERAPEUTICS INC 0.65%
CELCUITY INC 0.62%
PTC THERAPEUTICS INC 0.62%
GRAIL INC 0.62%
ULTRAGENYX PHARMACEUTICAL IN 0.62%
EXELIXIS INC 0.61%
IMMUNITYBIO INC 0.61%
IOVANCE BIOTHERAPEUTICS INC 0.61%
BIOCRYST PHARMACEUTICALS INC 0.6%
NEUROCRINE BIOSCIENCES INC 0.6%
UNITED THERAPEUTICS CORP 0.59%
BEAM THERAPEUTICS INC 0.57%
CELLDEX THERAPEUTICS INC 0.55%
VIRIDIAN THERAPEUTICS INC 0.55%
DENALI THERAPEUTICS INC 0.55%
IDEAYA BIOSCIENCES INC 0.54%
SAREPTA THERAPEUTICS INC 0.53%
IMMUNOME INC 0.51%
ALNYLAM PHARMACEUTICALS INC 0.5%
DISC MEDICINE INC 0.49%
VERA THERAPEUTICS INC 0.49%
IONIS PHARMACEUTICALS INC 0.49%
ARCUTIS BIOTHERAPEUTICS INC 0.48%
ARCUS BIOSCIENCES INC 0.48%
TANGO THERAPEUTICS INC 0.47%
MINERALYS THERAPEUTICS INC 0.47%
ADMA BIOLOGICS INC 0.47%
RECURSION PHARMACEUTICALS-A 0.47%
INTELLIA THERAPEUTICS INC 0.44%
SYNDAX PHARMACEUTICALS INC 0.43%
AGIOS PHARMACEUTICALS INC 0.43%
NURIX THERAPEUTICS INC 0.43%
PALVELLA THERAPEUTICS INC 0.41%
VERACYTE INC 0.41%
NOVAVAX INC 0.39%
KODIAK SCIENCES INC 0.38%
BIOHAVEN LTD 0.36%
CAREDX INC 0.35%
VERICEL CORP 0.34%
STOKE THERAPEUTICS INC 0.32%
ABSCI CORP 0.31%
CULLINAN THERAPEUTICS INC 0.3%
PRECIGEN INC 0.29%
ORIC PHARMACEUTICALS INC 0.29%
XENCOR INC 0.29%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.